Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat

Transplantation
M D VuH Chen

Abstract

Combined use of tacrolimus (FK506) with sirolimus (rapamycin [RAPA]) was examined in a model of vascularized heart allograft in the rat. For prevention of acute rejection, three different combinations of low doses of FK506 and RAPA from day 1 up to day 14 after transplantation produced significantly longer cardiac allograft survival than each agent alone (P<0.05). Identical results were observed in a model of reversal of ongoing acute rejection, where two combinations of low doses of FK506 and RAPA from day 4 up to day 18 after surgery also demonstrated significantly longer graft survival than each immunosuppressant alone (P<0.05). All the low-dose-treated groups in these two models presented significantly longer heart graft survival than naive controls (P<0.05), confirming that both agents are potent immunosuppressants in the models chosen. These results also indicate that, in contrast with in vitro studies, the combined use of FK506 and RAPA in vivo did not produce antagonism, but rather had synergistic effect in prolonging the allograft survival as compared with each agent alone. It appears likely that the abundance of FKBP-12 available for binding in vivo prevents inhibitive competition of the two agents for their receptor.

References

Jan 1, 1992·Annual Review of Immunology·N H Sigal, F J Dumont
Mar 1, 1991·The Journal of Experimental Medicine·N H SigalS L Koprak
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B E BiererS L Schreiber
Jan 1, 1994·Medicinal Research Reviews·S N SehgalB M Weichman
Nov 1, 1995·Current Opinion in Nephrology and Hypertension·S N SehgalB T Maida

❮ Previous
Next ❯

Citations

Oct 12, 2012·European Journal of Clinical Pharmacology·Michael A TortoriciAlain Patat
Mar 26, 2004·Transplantation Proceedings·T BerneyP Morel
Mar 26, 2004·Transplantation Proceedings·M H KapturczakB Kaplan
Jun 8, 2002·Archives of Biochemistry and Biophysics·Tomohito KakegawaHiroshi Kobayashi
Aug 15, 2002·Transplantation Proceedings·D MitalS C Jensik
May 14, 2003·Transplantation Proceedings·S M Stepkowski
May 14, 2003·Transplantation Proceedings·B J Hering, M Wijkstrom
May 14, 2003·Transplantation Proceedings·B Radovancevic, B Vrtovec
Sep 10, 2003·Transplantation Proceedings·P UssettiL Pulpón
Sep 2, 1998·Transplantation Proceedings·P A Keown, D R Primmett
Feb 9, 2000·Lancet·V C McAlisterA S MacDonald
Nov 25, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·U ChristiansG I Kirchner
Jan 3, 2001·Kidney International·R N SaundersM L Nicholson
Jul 10, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·P NeuhausJ M Langrehr
Oct 17, 2001·Transplantation·B D Kahan, J S Camardo
May 15, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Michael DetersVolkhard Kaever
Aug 23, 2002·Clinical Pharmacokinetics·Uwe ChristiansAlfonso Lampen
Sep 21, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sulaiman A Nanji, A M James Shapiro
Apr 13, 1999·Lancet·M D DentonM H Sayegh
Jun 7, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Lars Pape, Thurid Ahlenstiel
Jul 18, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sean P MontgomeryAllan D Kirk
Aug 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Karen Y DaneJeffrey A Hubbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.